EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $287,804 | -29.6% | 39,157 | -0.8% | 0.00% | -25.0% |
| Q1 2023 | $408,795 | +115705.9% | 39,459 | +32.2% | 0.00% | -20.0% |
| Q4 2022 | $353 | -99.9% | 29,850 | -6.5% | 0.01% | -54.5% |
| Q3 2022 | $670,000 | -34.0% | 31,920 | -2.4% | 0.01% | -31.2% |
| Q2 2022 | $1,015,000 | -27.2% | 32,692 | -3.7% | 0.02% | -15.8% |
| Q1 2022 | $1,394,000 | -7.1% | 33,945 | -1.7% | 0.02% | +5.6% |
| Q4 2021 | $1,501,000 | -15.2% | 34,520 | -2.4% | 0.02% | -18.2% |
| Q3 2021 | $1,770,000 | -17.2% | 35,355 | +4.2% | 0.02% | -12.0% |
| Q2 2021 | $2,138,000 | -32.0% | 33,943 | +0.3% | 0.02% | -35.9% |
| Q1 2021 | $3,145,000 | -3.0% | 33,847 | -6.4% | 0.04% | -4.9% |
| Q4 2020 | $3,241,000 | -25.4% | 36,172 | -13.9% | 0.04% | -30.5% |
| Q3 2020 | $4,342,000 | +56.0% | 42,020 | +19.3% | 0.06% | +34.1% |
| Q2 2020 | $2,784,000 | +29.0% | 35,209 | -5.6% | 0.04% | +10.0% |
| Q1 2020 | $2,158,000 | +33.3% | 37,289 | +24.2% | 0.04% | +60.0% |
| Q4 2019 | $1,619,000 | +3.7% | 30,015 | +0.5% | 0.02% | 0.0% |
| Q3 2019 | $1,561,000 | +5.3% | 29,853 | -2.8% | 0.02% | +8.7% |
| Q2 2019 | $1,483,000 | -4.1% | 30,698 | +0.3% | 0.02% | -8.0% |
| Q1 2019 | $1,546,000 | -11.1% | 30,592 | +4.3% | 0.02% | -19.4% |
| Q4 2018 | $1,739,000 | -4.6% | 29,337 | +5.9% | 0.03% | +24.0% |
| Q3 2018 | $1,823,000 | +58.1% | 27,696 | +21.3% | 0.02% | +56.2% |
| Q2 2018 | $1,153,000 | -5.7% | 22,830 | -1.7% | 0.02% | 0.0% |
| Q1 2018 | $1,223,000 | +10.7% | 23,222 | -2.4% | 0.02% | +14.3% |
| Q4 2017 | $1,105,000 | +6.9% | 23,784 | -7.0% | 0.01% | +7.7% |
| Q3 2017 | $1,034,000 | +20.0% | 25,574 | +0.6% | 0.01% | +18.2% |
| Q2 2017 | $862,000 | +18.6% | 25,417 | +1.5% | 0.01% | +22.2% |
| Q1 2017 | $727,000 | -11.9% | 25,040 | -0.3% | 0.01% | -18.2% |
| Q4 2016 | $825,000 | -0.1% | 25,108 | -4.2% | 0.01% | 0.0% |
| Q3 2016 | $826,000 | +22.9% | 26,198 | +9.7% | 0.01% | +22.2% |
| Q2 2016 | $672,000 | -24.7% | 23,892 | -2.7% | 0.01% | -18.2% |
| Q1 2016 | $892,000 | -11.4% | 24,547 | -2.4% | 0.01% | -8.3% |
| Q4 2015 | $1,007,000 | +41.2% | 25,162 | +0.6% | 0.01% | +33.3% |
| Q3 2015 | $713,000 | -15.0% | 25,018 | -1.7% | 0.01% | -10.0% |
| Q2 2015 | $839,000 | +9.5% | 25,452 | -4.5% | 0.01% | +25.0% |
| Q1 2015 | $766,000 | +6.7% | 26,638 | +1.0% | 0.01% | 0.0% |
| Q4 2014 | $718,000 | +27.1% | 26,369 | -0.5% | 0.01% | +33.3% |
| Q3 2014 | $565,000 | -15.8% | 26,509 | -11.3% | 0.01% | -14.3% |
| Q2 2014 | $671,000 | -9.4% | 29,879 | +1.9% | 0.01% | -12.5% |
| Q1 2014 | $741,000 | +6.6% | 29,322 | -3.0% | 0.01% | +14.3% |
| Q4 2013 | $695,000 | +20.2% | 30,228 | -0.4% | 0.01% | +16.7% |
| Q3 2013 | $578,000 | +39.3% | 30,340 | +5.5% | 0.01% | +50.0% |
| Q2 2013 | $415,000 | +3.8% | 28,757 | +0.4% | 0.00% | 0.0% |
| Q1 2013 | $400,000 | – | 28,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
| GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
| Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
| ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
| RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
| NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
| Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |